HO902DLBCL: A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients
Study Details
Study Description
Brief Summary
Observational prospective study. Patients with DLBCL and HGBCL will be enrolled in the study to collect samples for developing a blood based assay allowing biomarker driven treatment in the future.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The rationale of this study is that, due to the lack of successful salvage options, first-line treatment outcome needs to be improved. To make this possible, a crucial condition is optimal identification of patients that will not be cured on R-CHOP. The aim of this protocol is to develop new tools to monitor treatment response and disease outcome. Molecular monitoring of treatment response through liquid biopsies (LB) is such a promising new tool.
The primary objective is to collect liquid biopsy samples of patients with newly diagnosed DLBCL/HGBCL to develop a blood based assay allowing biomarker driven treatment in the future.
The secondary objectives are to collect clinical data and pre-treatment tissue samples (for determining molecular profiles) to allow for correlation to the blood based assay.
This study is designed for patients with newly diagnosed DLBCL and HGBCL ≥ 18 yr.
Study Design
Outcome Measures
Primary Outcome Measures
- Tissue material [24 months]
For genomic analysis and clinical outcome data
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients diagnosed with newly diagnosed DLBCL (including HGBCL- NOS and HGBCL-DH) according to WHO classification 2016
-
Ann Arbor stage II-IV
-
Patients intended to be treated with 6 cycles R-CHOP (or DA-EPOCH-R) as first-line treatment (successive inclusion in HOVON 151 or HOVON 152 is possible)
-
Age ≥ 18 years
Exclusion Criteria:
- Patients with limited stage I, II disease planned to receive 3 cycles of R-CHOP + radiotherapy, or 4 x R-CHOP+ 2R
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | NL-Alkmaar-NWZ | Alkmaar | Netherlands | ||
2 | NL-Almelo-ZGTALMELO | Almelo | Netherlands | ||
3 | NL-Almere-FLEVOZIEKENHUIS | Almere | Netherlands | ||
4 | NL-Amersfoort-MEANDERMC | Amersfoort | Netherlands | ||
5 | NL-Amstelveen-AMSTELLAND | Amstelveen | Netherlands | ||
6 | NL-Amsterdam-AMC | Amsterdam | Netherlands | ||
7 | NL-Amsterdam-OLVG | Amsterdam | Netherlands | ||
8 | NL-Amsterdam-VUMC | Amsterdam | Netherlands | ||
9 | NL-Arnhem-RIJNSTATE | Arnhem | Netherlands | ||
10 | NL-Assen-WZA | Assen | Netherlands | ||
11 | NL-Beverwijk-RKZ | Beverwijk | Netherlands | ||
12 | NL-Breda-AMPHIA | Breda | Netherlands | ||
13 | NL-Capelle a/d IJssel-YSL | Capelle Aan Den IJssel | Netherlands | ||
14 | NL-Delft-RDGG | Delft | Netherlands | ||
15 | NL-Den Bosch-JBZ | Den Bosch | Netherlands | ||
16 | NL-Den Haag-HAGA | Den Haag | Netherlands | ||
17 | NL-Den Haag-HMCWESTEINDE | Den Haag | Netherlands | ||
18 | NL-Deventer-DZ | Deventer | Netherlands | ||
19 | NL-Dirksland-VANWEELBETHESDA | Dirksland | Netherlands | ||
20 | NL-Doetinchem-SLINGELAND | Doetinchem | Netherlands | ||
21 | NL-Dordrecht-ASZ | Dordrecht | Netherlands | ||
22 | NL-Ede-ZGV | Ede | Netherlands | ||
23 | NL-Eindhoven-CATHARINA | Eindhoven | Netherlands | ||
24 | NL-Eindhoven-MAXIMAMC | Eindhoven | Netherlands | ||
25 | NL-Emmen-SCHEPER | Emmen | Netherlands | ||
26 | NL-Enschede-MST | Enschede | Netherlands | ||
27 | NL-Geldrop-STANNA | Geldrop | Netherlands | ||
28 | NL-Goes-ADRZ | Goes | Netherlands | ||
29 | NL-Gorinchem-BEATRIX | Gorinchem | Netherlands | ||
30 | NL-Gouda-GROENEHART | Gouda | Netherlands | ||
31 | NL-Groningen-UMCG | Groningen | Netherlands | ||
32 | NL-Hardenberg-SAXENBURGH | Hardenberg | Netherlands | ||
33 | NL-Harderwijk-STJANSDALHARDERWIJK | Harderwijk | Netherlands | ||
34 | NL-Heerenveen-TJONGERSCHANS | Heerenveen | Netherlands | ||
35 | NL-Helmond-ELKERLIEK | Helmond | Netherlands | ||
36 | NL-Hoofddorp-SPAARNEGASTHUIS | Hoofddorp | Netherlands | ||
37 | NL-Hoorn-DIJKLANDERHOORN | Hoorn | Netherlands | ||
38 | NL-Leeuwarden-MCL | Leeuwarden | Netherlands | ||
39 | NL-Leiden-LUMC | Leiden | Netherlands | ||
40 | NL-Maastricht-MUMC | Maastricht | Netherlands | ||
41 | NL-Nieuwegein-ANTONIUS | Nieuwegein | Netherlands | ||
42 | NL-Nijmegen-CWZ | Nijmegen | Netherlands | ||
43 | NL-Roermond-LZR | Roermond | Netherlands | ||
44 | NL-Roosendaal-BRAVIS | Roosendaal | Netherlands | ||
45 | NL-Rotterdam-ERASMUSMC | Rotterdam | Netherlands | ||
46 | NL-Rotterdam-IKAZIA | Rotterdam | Netherlands | ||
47 | NL-Rotterdam-MAASSTADZIEKENHUIS | Rotterdam | Netherlands | ||
48 | NL-Rotterdam-SFG | Rotterdam | Netherlands | ||
49 | NL-Sneek-ANTONIUSSNEEK | Sneek | Netherlands | ||
50 | NL-Spijkenisse-SPIJKENISSEMC | Spijkenisse | Netherlands | ||
51 | NL-Terneuzen-ZORGSAAM | Terneuzen | Netherlands | ||
52 | NL-Tiel-RIVIERENLAND | Tiel | Netherlands | ||
53 | NL-Tilburg-ETZ | Tilburg | Netherlands | ||
54 | NL-Uden-BERNHOVEN | Uden | Netherlands | ||
55 | NL-Utrecht-DIAKONESSENUTRECHT | Utrecht | Netherlands | ||
56 | NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | ||
57 | NL-Venlo-VIECURI | Venlo | Netherlands | ||
58 | NL-Winterswijk-SKBWINTERSWIJK | Winterswijk | Netherlands | ||
59 | NL-Zutphen-GELREZUTPHEN | Zutphen | Netherlands | ||
60 | NL-Zwolle-ISALA | Zwolle | Netherlands |
Sponsors and Collaborators
- Stichting Hemato-Oncologie voor Volwassenen Nederland
Investigators
- Principal Investigator: M.E.D. Chamuleau, MD, PhD, VUmc
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HO902